Log in or Sign up for Free to view tailored content for your specialty!
Endocrinology News
Q&A: New initiative to address CKM syndrome, affecting millions in the US
In October 2023, the American Heart Association unveiled the term cardiovascular-kidney-metabolic syndrome to reflect the connection between metabolic and renal conditions associated with risk for heart disease.
Voluntary medical device correction issued for small subset of FreeStyle Libre 3 sensors
A voluntary medical device correction has been issued for a small number of continuous glucose monitoring sensors distributed in the first half of May, according to an industry press release.
Log in or Sign up for Free to view tailored content for your specialty!
Postprandial insulin may cut hypoglycemia rates for hospitalized adults with diabetes
Changing in-hospital nutritional insulin administration from before meals to after meals lowered hypoglycemia rates at a community hospital, according to study findings published in Diabetes Research and Clinical Practice.
Gastric bypass for obesity lowers major atherogenic blood lipids vs. very low-energy diet
Patients with severe obesity undergoing Roux-en-Y gastric bypass for weight loss demonstrated greater reductions in blood lipids at 6 weeks vs. those on a very low-energy diet, according to study results in JAMA Surgery.
Immunotherapy to treat early-stage type 1 diabetes receives FDA fast track designation
An immunotherapy to treat type 1 diabetes for people with the human leukocyte antigen DR3-DQ2 genotype received its second fast-track designation from the FDA, according to a company press release.
Risk for heart, liver disease may vary between PCOS subtypes
Women with polycystic ovary syndrome and high androgen levels may have a higher risk for liver disease than those with PCOS and normal androgen levels, according to an analysis of UK Biobank data.
Child-onset diabetes linked to high risk for mental health disorders later in life
Individuals who develop type 1 diabetes during childhood experienced greater risk for several mental health conditions later in life, including anxiety disorders and substance use disorders, study results showed.
GLP-1 receptor agonist prescriptions for obesity have risen in those without diabetes
New prescriptions of GLP-1 receptor agonists for the treatment of obesity have increased significantly among individuals without type 2 diabetes in the last decade, according to a study in Annals of Internal Medicine.
Weight-loss surgery appears to benefit patients with heart failure, obesity
In a single-center cohort of patients with heart failure and obesity, weight-loss surgery led to improved clinical outcomes including reduced BMI and HbA1c and less reliance on diuretics, researchers reported.
Semaglutide does not raise risk for neurologic disorders for adults with type 2 diabetes
Semaglutide was not associated with increased risks for adverse neurologic or psychological disorders at 1 year compared with other diabetes drugs, according to data published in eClinicalMedicine.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read